"Alcohol Based Hand Sanitizers for the Prevention of Acute Diarrheal Disease and Acute Respiratory Infection in Children Under 5 Attending Childcare Centers in Bogotá, Cundinamarca and Tolima, in Colombia: a Cluster Randomized Control Trial"

Acute Respiratory Infection Clinical Trial

Official title:
"Alcohol Based Hand Sanitizers for the Prevention of Acute Diarrheal Disease and Acute Respiratory Infection in Children Under 5 Attending Childcare Centers in Bogotá, Cundinamarca and Tolima, in Colombia: a Cluster Randomized Control Trial"

Status Completed

Clinical Trial Summary

The purpose of this study is to conduct a Randomized Control Trial (RCT) in a developing country setting in order to evaluate the role of alcohol based hand sanitizers (ABHS) in preventing the transmission of infectious diseases in areas where water is a scarce resource. The investigators want to find out if the use of ABHS reduces the incidence of two leading causes of morbidity and mortality in children under 5 years of age in the developing world: acute diarrheal disease (ADD) and acute respiratory infections (ARI).

Clinical Trial Description

We performed a cluster, RCT in child care centers located in six urban settings of Colombia with intermittent tap water availability. A total of 1727 children between 1 and 5 years of age distributed in 42 childcare centers participated in the study. The intervention consisted on installation of ABHS gel dispensers and training on their use by participating children in child care centers. Centers assigned to the control group were recommended to continue with current hand hygiene practices. Child care centers matched by location, size and sanitary conditions were randomly assigned to intervention or control. Cases of Acute Diarrheal Disease (ADD) and Acute Respiratory Infections ARI were identified through teacher reported signs and symptoms of disease and validated by a trained physician. We also monitored adverse events potentially related to ABHS. To compare incidence rates between study arms we modeled the number of episodes of ADD and ARI per child using a Cox proportional hazards multiple regression with random effects. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00963391
Study type	Interventional
Source	Fundación Santa Fe de Bogota
Contact
Status	Completed
Phase	N/A
Start date	February 2008
Completion date	December 2008

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03943654` - Improving Nighttime Access to Care and Treatment (Part 2)
Completed	`NCT05269290` - Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral Infections	Phase 3
Completed	`NCT06385821` - A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus	Phase 3
Not yet recruiting	`NCT05902702` - Isotonic Saline for Children With Bronchiolitis	N/A
Not yet recruiting	`NCT04525118` - Wide Scale Monitoring for Acute Respiratory Infection Using a Mobile-based Study Platform
Completed	`NCT01431469` - Efficacy and Tolerance of a Follow-On Formula Fed to Children From 12-48 Months of Age in Salvador, Bahia, Brazil	N/A
Completed	`NCT00981513` - Direct and Indirect Benefits of Influenza Vaccination in Schools and Households	Phase 4
Recruiting	`NCT06183229` - Cycloferon for Post-exposure Prophylaxis of Acute Respiratory Viral Infections and Influenza	Phase 3
Completed	`NCT03274310` - FluSAFE: Flu SMS Alerts to Freeze Exposure	N/A
Completed	`NCT03736096` - Molecular Diagnosis of Respiratory Viral Infections on Sputum From Cystic Fibrosis Patients
Completed	`NCT03189537` - Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections	Phase 3
Completed	`NCT03028077` - Effects of GS-3K8 and GINst15 on Acute Respiratory Illness	N/A
Enrolling by invitation	`NCT01286285` - Surveillance of Influenza in Paediatric Intensive Care Units in Bavaria	N/A
Completed	`NCT03840135` - Efficacy and Safety of Polyoxidonium, Nasal and Sublingual Spray, 6 mg/ml in Children Aged 1-12 Years With ARI	Phase 3
Completed	`NCT01488435` - Efficacy and Tolerance of a Follow-On Formula Fed to Children From 36-48 Months of Age	N/A
Not yet recruiting	`NCT00545961` - Middle Meatal Bacteriology During Acute Respiratory Infection in Children	Phase 4
Completed	`NCT05273619` - Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection	Phase 3
Recruiting	`NCT04415827` - Energy Supply in Athletes and Untrained Persons With Bronchopulmonary Diseases	N/A
Completed	`NCT03459391` - Study to Assess Safety, Tolerability and Pharmacokinetics of XC221 in Healthy Volunteers	Phase 1
Withdrawn	`NCT04938323` - Prevention of Acute Respiratory Infection in Taiwanese Institutionalized Elderly	Phase 2/Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.